This tablet is taken orally.

‍

Renglipt M 500 Tablet consists of two primary components:

• Teneligliptin (20 mg): As a dipeptidyl peptidase-4 (DPP-4) inhibitor, teneligliptin prevents the breakdown of incretin hormones, which enhances insulin synthesis and release in the presence of glucose.

• Metformin Hydrochloride (500 mg): This component reduces hepatic glucose production, decreases intestinal glucose absorption, and improves insulin sensitivity.

‍

Drug-Drug Interactions

• Carbonic Anhydrase Inhibitors: May increase the risk of lactic acidosis.

• Medicines Reducing Metformin Clearance: May lead to metformin accumulation.

• Beta-Blockers: Can enhance hypoglycaemic effects, posing a risk of low blood sugar levels.

Drug-Food Interactions

• High-Fat Meals: May reduce the efficacy of the medication.

Drug-Disease Interactions

• Type 1 Diabetes: Contraindicated as it is not effective for this condition.

• Diabetic Ketoacidosis: Not recommended due to the risk of exacerbation.

‍

Daily Dose

• This tablet should be taken as prescribed by your doctor, based on your condition and response to the medication.

Missed Dose

• If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not double the dose to compensate for a missed one.

Overdose

• Overdose symptoms may include diarrhoea, upset stomach, and fatigue. Seek medical attention immediately if these occur.

‍

• Store below 30°C.

• Keep away from light and moisture.

• Ensure the product is out of reach of children.

• Check the expiry date before use.

‍

• Incorporate low glycaemic index foods into your diet to help maintain stable blood sugar levels.

• Engage in regular physical activity to improve insulin sensitivity and manage diabetes effectively.

‍